Table 3.
Group | Drug | Frequency | Percent (n/N) b |
---|---|---|---|
β-lactam | 26 | 28.9 (26/90) | |
Penicillin | PenicillinG | 11 | 29.0 (11/27) |
Ampicillin | 12 | 32.4 (12/26) | |
Cephalosporin | Cephalothin | 1 | 2.7 (1/37) |
Ceftiofur | 1 | 2.7 (1/37) | |
Combination | Amoxicillin/Clavulanic acid | 1 | 2.7 (1/37) |
Tetracycline | Doxycycline | 1 | 2.7 (1/37) |
Fluoroquinolone | 6 | 8.6 (6/70) | |
Enrofloxacin | 3 | 7.9 (3/35) | |
Orbifloxacin | 3 | 7.9 (3/35) | |
Aminoglycoside | 4 | 3.6 (4/110) | |
Gentamicin | 1 | 2.7 (1/37) | |
Amikacin | 1 | 2.7 (1/37) | |
Kanamycin | 2 | 5.3 (2/36) | |
Potentiated sulfonamide | Sulfamethoxazole/trimethoprim | 4 | 10.5 (4/34) |
Amphenicols | Chloramphenicol | 2 | 5.2 (2/36) |
Lincosamides | Clindamycin | 13 | 34.2 (13/25) |
Aminoglycoside-lincosamide | Lincospectin | 12 | 31.6 (12/26) |
Macrolide | Tylosin | 2 | 5.3 (2/36) |
b = n is the number resistant, N is number tested